Is 72 mg Ferrous Bisglycinate Twice Daily a Low Dose?
No, 72 mg ferrous bisglycinate twice daily (144 mg total elemental iron per day) is not a low dose—it exceeds current guideline-recommended dosing and provides no additional absorption benefit while potentially increasing gastrointestinal side effects.
Guideline-Recommended Dosing for Iron Deficiency Anemia
The most recent high-quality guidelines establish clear dosing thresholds:
The 2024 AGA and 2021 British Society of Gastroenterology guidelines strongly recommend 50–100 mg elemental iron once daily as the optimal initial treatment for iron deficiency anemia in adults. 1, 2
Once-daily dosing is superior to multiple daily doses because a single 60 mg dose of elemental iron raises hepcidin levels for up to 48 hours, blocking further iron absorption during that window. 2
Twice-daily dosing does not improve total iron absorption compared with once-daily dosing but significantly increases gastrointestinal adverse events. 2
Your Regimen in Context
Your proposed regimen delivers:
- 144 mg elemental iron per day (72 mg × 2 doses)
- This is 44–188% higher than the recommended 50–100 mg once-daily dose 1, 2
- This is 80–120% of the historical 150–200 mg daily dose, which recent evidence shows is excessive 3
Why This Dose Is Problematic
Pharmacokinetic evidence demonstrates that 60 mg elemental iron once daily yields overall absorption comparable to 60 mg twice daily, making the second dose physiologically futile. 2
Key pitfalls to avoid:
- Do not prescribe twice- or three-times-daily dosing as first-line; it raises side effects without improving absorption 2
- The standard practice of using higher divided doses is not supported by current evidence 1
- Gastrointestinal adverse events (nausea, constipation, diarrhea) occur in 12–31% of patients on oral ferrous sulfate and are dose-dependent 2
Recommended Dosing Strategy
Start with 50–100 mg elemental iron once daily on an empty stomach (≥1 hour before or 2 hours after food). 1, 2
If gastrointestinal intolerance occurs:
- Switch to alternate-day dosing (one dose every other day), which reduces GI side effects (relative risk 0.56) while maintaining comparable final hemoglobin increments 1, 2
- Consider taking with meals, accepting modest reduction in absorption 2
- Do not switch to a different traditional iron salt; evidence does not support this practice 1
Ferrous Bisglycinate-Specific Evidence
While ferrous bisglycinate may offer better tolerability than iron salts:
- A 2023 meta-analysis found ferrous bisglycinate increased hemoglobin in pregnant women with fewer GI adverse events (incidence rate ratio 0.36) 4
- However, a 2023 noninferiority trial in Cambodian women found 18 mg ferrous bisglycinate was inferior to 60 mg ferrous sulfate in increasing ferritin concentrations 5
- A 2014 RCT showed 25 mg ferrous bisglycinate was as effective as 50 mg ferrous sulfate in preventing iron deficiency during pregnancy 6
The evidence suggests ferrous bisglycinate may be effective at lower elemental iron doses (18–27 mg daily) due to superior bioavailability, but your 144 mg daily dose far exceeds this. 7, 8, 6
Monitoring and Treatment Failure
Check hemoglobin after 2 weeks of therapy; an increase of ≥10 g/L (≥1 g/dL) indicates effective response with 90% sensitivity for predicting treatment success. 1, 2
If no hemoglobin rise occurs after 2 weeks of adherent therapy:
- Assess for non-adherence, malabsorption, ongoing blood loss, or concurrent B12/folate deficiency 1
- Switch to intravenous iron rather than increasing oral dose 1, 2
After hemoglobin normalizes, continue oral iron for 2–3 months to replenish stores, then monitor hemoglobin every 3–6 months for 2–3 years to detect recurrence. 1, 2